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ABSTRACT
Metabolomics is a newly emerging field of ‘omics’
research that is concerned with characterizing large
numbers of metabolites using NMR, chromatogra-
phy and mass spectrometry. It is frequently used
in biomarker identification and the metabolic profil-
ing of cells, tissues or organisms. The data proces-
sing challenges in metabolomics are quite unique
and often require specialized (or expensive) data
analysis software and a detailed knowledge of che-
minformatics, bioinformatics and statistics. In an
effort to simplify metabolomic data analysis while
at the same time improving user accessibility, we
have developed a freely accessible, easy-to-use
web server for metabolomic data analysis called
MetaboAnalyst. Fundamentally, MetaboAnalyst is
a web-based metabolomic data processing tool
not unlike many of today’s web-based microarray
analysis packages. It accepts a variety of input
data (NMR peak lists, binned spectra, MS peak
lists, compound/concentration data) in a wide vari-
ety of formats. It also offers a number of options for
metabolomic data processing, data normalization,
multivariate statistical analysis, graphing, metabo-
lite identification and pathway mapping. In particu-
lar, MetaboAnalyst supports such techniques as:
fold change analysis, t-tests, PCA, PLS-DA, hierar-
chical clustering and a number of more sophisti-
cated statistical or machine learning methods. It
also employs a large library of reference spectra to
facilitate compound identification from most kinds
of input spectra. MetaboAnalyst guides users
through a step-by-step analysis pipeline using a
variety of menus, information hyperlinks and check
boxes. Upon completion, the server generates a
detailed report describing each method used,
embedded with graphical and tabular outputs.
MetaboAnalyst is capable of handling most kinds
of metabolomic data and was designed to perform
most of the common kinds of metabolomic data
analyses. MetaboAnalyst is accessible at http://
www.metaboanalyst.ca
INTRODUCTION
Metabolomics is a ﬁeld of ‘omics’ science that aims
to study global metabolic changes in biological systems
(1). It is largely based on the use of nuclear magnetic res-
onance (NMR) spectroscopy, gas chromatography mass
spectrometry (GC–MS) and liquid chromatography mass
spectrometry (LC–MS) to detect, identify and quantify
small molecule metabolites from biological tissues and
bioﬂuids (2). Typically hundreds to thousands of com-
pounds or spectral features can be seen in a typical
high throughput metabolomic assay. While still a
relatively new member of the ‘omics’ family, metabolo-
mics is already ﬁnding applications in a wide variety
of research ﬁelds including disease diagnosis (3), drug
toxicity studies (4) and functional genomics (5). With the
rapid growth of this ﬁeld, there is an increasing demand
for dedicated software tools that support the processing
and analysis of metabolomic data from a variety of ana-
lytical platforms.
There are two major approaches to analyzing metabo-
lomic data—chemometric approaches and quantitative
approaches (2). With chemometric approaches the com-
pounds are not initially identiﬁed—only their spectral pat-
terns and intensities are recorded, statistically compared
and used to identify the relevant spectral features that
distinguish sample classes. Once these features have been
identiﬁed, a variety of approaches may then used to iden-
tify the metabolites corresponding to the most important
features. Chemometric approaches can be applied to data
acquired by NMR, Fourier transform infrared spectros-
copy (FTIR) and direct injection mass spectrometry
(DIMS). In contrast to chemometric approaches, quanti-
tative metabolomics (or targeted proﬁling) aims to for-
mally identify and quantify all detectable metabolites
from the spectra, prior to subsequent data analysis.
Metabolites are identiﬁed and quantiﬁed by comparing
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sample of interest to a set of authentic (isotopically
labeled) standards or to a spectral reference library
obtained from authentic standards. This approach
requires that the compounds of interest to be known a
priori. With the availability of several comprehensive
metabolomic databases (6–9) and metabolome libraries,
quantitative metabolomics is becoming increasingly
common.
Whether the resulting data is chemometric data or
quantitative data, what is not commonly realized by
many metabolomics researchers is that metabolomics
data share a great deal of similarity with microarray
data. Both types of data matrices are large and feature
rich. Likewise the objectives in microarray analysis are
similar to those in metabolomic analysis. For example,
both kinds of studies are aimed at identifying signiﬁcant
features associated with certain conditions (biomarker dis-
covery) or for diagnosis (classiﬁcation). Furthermore,
both kinds of studies are often challenged with the
problem of dealing with a limited sample size and a
high-dimensional feature space. By using the robust data
processing algorithms originally developed for microarray
analysis and applying them to metabolomic analysis, we
believed it could be possible to create a powerful suite of
tools for metabolomic data processing. In particular,
we chose to work with the resources available from the
open source R-project (http://www.R-project.org) and the
R-based Bioconductor project (10). These software repo-
sitories are widely considered to be the most complete
collection of up-to-date statistical and machine learning
algorithms for microarray data analysis. The algorithms
are actively developed and conscientiously maintained by
R-project team members and external contributors.
In many respects they have become the reference tools
for the microarray ﬁeld. By combining these R-based ana-
lytical tools with metabolite identiﬁcation and pathway
mapping tools originally developed in our own laboratory
(6,11), we have created MetaboAnalyst—a web-based
server for processing, analyzing, visualizing and annotat-
ing high throughput metabolomic data.
In particular, MetaboAnalyst is able to process a wide
variety of metabolomic data types including compound
concentration tables (for quantitative metabolomics) as
well as spectrally binned data, NMR/MS peak lists and
GC/LC-MS spectra (NetCDF, mzXML, mzDATA—for
chemometric metabolomics). It also provides a compre-
hensive list of analysis options for normalization, feature
identiﬁcation, dimensional reduction clustering and
classiﬁcation. Furthermore, MetaboAnalyst produces
colorful graphical output and it supports a number of
compound identiﬁcation and pathway mapping tools for
data annotation. Additional details about the server, its
interface and its analytical features are provided in the
following pages.
PROGRAM DESCRIPTION AND METHODS
MetaboAnalyst’s web interface was developed using Java
Server Faces (JSF) technology (http://java.sun.com/
javaee/javaserverfaces). The backend statistical computing
and visualization operations were carried out using
functions from the R and Bioconductor packages.
The integration between Java and R was established
through the Rserve package (http://www.rforge.net/
Rserve). Spectral matching and pathway identiﬁcation
software was developed in Java using the spectral libraries
and pathway libraries developed for the Human
Metabolome Project (6) and MetaboMiner (11).
JSF is a very powerful technology for developing
Java-based web applications. It is designed to simplify
the development of user interfaces for Java Enterprise
Edition (Java EE) applications by automatic handling of
low level HTTP requests and user input processing. JSF
uses a component-based model for web development.
Using the visual JSF web application tool oﬀered by the
NetBeans (http://www.netbeans.org) integrated develop-
ment environment (IDE), components can be literally
‘painted’ on a virtual JSF page by dragging-and-dropping
them from a palette of JSF component library. Event
handlers can then be deﬁned for each component the
same way as for developing standalone Java graphic
user interface (GUI) application. Finally, navigation
rules are speciﬁed for each page from a central XML con-
ﬁguration ﬁle (faces-conﬁg.xml). User actions on a web
interface will trigger an event whose return value deter-
mines which page is to be displayed subsequently based on
the navigation rules speciﬁed for that page. This approach
facilitates modular and ﬂexible design, making web appli-
cation development much simpler and faster.
MetaboAnalyst consists of several functional modules
which will be discussed, in detail, later. These functions
are carried out by several R scripts and Bioconductor
function calls. Detailed information about the individual
packages used and the R scripts can be downloaded from
the MetaboAnalyst home page. When MetaboAnalyst
is run, the executed R commands are recorded to a tem-
porary text ﬁle. During the summary report generation,
this R command history is examined and the last call for
each analysis performed is re-evaluated using the R
Sweave function which executes the R commands and
writes text descriptions along with tabular and graphical
results into a LaTeX ﬁle. Finally, the LaTeX ﬁle is con-
verted into a PDF report describing the analysis, which is
available to the user for download.
MetaboAnalyst is currently hosted on GlassFish
(version 2 update release 2, https://glassﬁsh.dev.java.net)
installed on a Linux operating system (Fedora Core 9).
The server is equipped with two Intel Pentium 4 proces-
sors (2.8GHz each) and 4GB of physical memory.
The web application is platform independent and has
been tested successfully under both Linux and Windows
operating systems. R (version 2.8.0) is currently installed
on the same machine with latest Bioconductor release 2.3
and Rserve 0.5–2.
A diagram illustrating MetaboAnalyst’s workﬂow is
shown in Figure 1. MetaboAnalyst is not a ‘single-click’
analysis tool, but rather it is an on-line analysis pipeline
similar in concept to several existing on-line microarray
analysis tools such as GEPAS (12) and CARMAweb (13).
It is primarily designed to allow users to conduct
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trol—the most common type of metabolomic analysis) for
classiﬁcation and ‘signiﬁcant feature’ identiﬁcation.
MetaboAnalyst also supports both paired and unpaired
data analyses. A typical MetaboAnalyst run consists of
six steps: (i) data upload, (ii) processing, (iii) normaliza-
tion, (iv) statistical analysis, (v) annotation and (vi) sum-
mary report download. Users are guided through these
steps by MetaboAnalyst’s intuitive interface and the nav-
igation bar on the left panel of each page. Completed steps
are indicated by a change in color. Certain downstream
analyses may not be allowed depending on the context or
type of analyses previously performed. Detailed descrip-
tions, help ﬁles or helpful hints are either shown on the
corresponding web pages or are provided as mouse-over
pop-up balloons. This support is further enhanced by
the availability of several step-by-step tutorials, sample
data sets (NMR, GC/LC–MS, binned data, etc.), sample
summary ﬁles and frequently asked questions (FAQs)
available on MetaboAnalyst’s web site.
Step 1: data upload
Users can begin a MetaboAnalyst analysis by pressing the
‘Click Here to Start’ link on the MetaboAnalyst’s home
page. This takes users to the data upload page. Because
there is no widely-accepted standard format for reporting
metabolomics experiments MetaboAnalyst has been
designed to accept diverse data types including compound
concentration tables (from quantitative metabolomic stu-
dies), binned spectral data, NMR or MS peak lists, as well
as raw GC–MS and raw LC–MS spectra. For compound
concentration or binned spectral data, MetaboAnalyst
requires that they be uploaded as a comma separated
values (CSV) table with class labels (control and abnor-
mal, say) immediately following the sample names. For
peak list data, MetaboAnalyst requires that they be
uploaded as two zipped folders containing peak list ﬁles
from the two respective groups. Each ﬁle should be a two
or three-column CSV list indicating peak positions (che-
mical shift for NMR peaks, mass and/or retention time for
MS peaks) and intensities, respectively. Examples of these
formats and more detailed explanations of the formatting
requirements are provided on the MetaboAnalyst home
page. Vendor-speciﬁc, proprietary GC–MS or LC–MS
spectra should be ﬁrst converted to open exchange ﬁle
formats (NetCDF, mzXML, mzDATA) and uploaded as
two zipped folders corresponding to the two groups being
analyzed. Detailed instructions on how to specify paired
Figure 1. A diagram illustrating MetaboAnalyst’s workﬂow and data processing options. Diﬀerent data inputs are ﬁrst transformed into compatible
data matrices using several diﬀerent processing methods. A variety of algorithms are implemented for data normalization, analysis, and annotation.
The number of available options is shown inside the round brackets for each category. At the end of any given analysis, a comprehensive PDF
report, the processed data, and high-resolution images are available for download.
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for each data type are available through MetaboAnalyst’s
‘Data Formats’ link on the home page.
Step 2: data processing and data integrity checking
Depending on the type of uploaded data, diﬀerent pro-
cessing strategies can be employed to convert the raw
numbers into a data matrix suitable for downstream ana-
lysis. For compound concentration lists, the data can be
used immediately after MetaboAnalyst’s data integrity
check. For binned spectral data, a linear ﬁlter is ﬁrst
applied in order to remove baseline noise. This is done
because most data processing algorithms do not work
properly with many near-zero values. For NMR and/or
MS peak lists, MetaboAnalyst ﬁrst groups the peaks
across all samples based on their positions. For GC–MS
and LC–MS spectra or total ion chromatograms, the pro-
gram performs peak detection, peak grouping, and reten-
tion time correction sequentially using the popular XCMS
package (14). Users can adjust the default parameters for
each processing step.
Often there are large numbers of missing values in a
typical quantitative metabolomics dataset (10–40% in
our experience). Most of these missing values are due to
various compounds in certain samples being below the
instrument detection limits. To allow selected analyses to
proceed (without divide-by-zero problems) these missing
values are replaced by the half of the minimum value
found in the dataset by default. We also implemented a
variety of methods which enable users to manually or
automatically perform missing value exclusion, missing
value replacement, as well as missing value imputation
by Probabilistic PCA (PPCA), Bayesian PCA (BPCA)
and Singular Value Decomposition Imputation
(SVDImpute) (15,16). In addition, as part of the data
integrity check, MetaboAnalyst also veriﬁes class labels
and pair speciﬁcation (if applicable) to make sure all
the required information is present and consistent before
proceeding to the next step.
Step 3: data normalization
At this stage, the uploaded data is compiled into a table in
which each sample is formally represented by a row and
each feature identiﬁes a column. With the data structured
in this format, two types of data normalization proto-
cols—row-wise normalization and column-wise normali-
zation—may be used. These are often applied sequentially
to reduce systematic variance and to improve the perfor-
mance for downstream statistical analysis. Row-wise nor-
malization aims to normalize each sample (row) so that it
is comparable to the other. Four commonly used metabo-
lomic normalization methods have been implemented in
MetaboAnalyst, including normalization to a constant
sum, normalization to a reference sample (probabilistic
quotient normalization) (17), normalization to a reference
feature (creatinine or an internal standard) and sample-
speciﬁc normalization (dry weight or tissue volume).
In contrast to row-wise normalization, column-wise
normalization aims to make each feature (column) more
comparable in magnitude to the other. Four widely-used
methods are oﬀered in MetaboAnalyst—log transforma-
tion, auto-scaling, Pareto scaling and range scaling.
Given the vast dynamic range of many features (com-
pound concentration or ion abundance) in metabolomics
data, normalization is highly recommended. The eﬀects
and utility of these diﬀerent normalization strategies
have been discussed in detail elsewhere (18) and are
described further in MetaboAnalyst’s online tutorials.
Step 4: data analysis
MetaboAnalyst’s data analysis module is a collection of
well-established statistical and machine learning algo-
rithms that have been shown to be particularly robust
for high-dimensional data analysis. These algorithms are
organized into ﬁve analysis ‘paths’ for users to explore.
Univariate analysis path. Because of their simplicity and
interpretability, univariate analyses are often ﬁrst used to
obtain an overview or rough ranking of potentially impor-
tant features before applying more sophisticated analyses.
Univariate analysis examines each variable separately and
does not consider the eﬀect of multiple comparisons.
MetaboAnalyst’s univariate analysis path supports three
commonly used methods—fold-change analysis, t-tests
and volcano plots. In a t-test one attempts to determine
whether the means of two groups are distinct. Once a
t-value is determined, a P-value can be calculated that
can be used to determine whether this distinction is statis-
tically signiﬁcant. Both paired (same individuals measured
before and after an intervention) and unpaired (indivi-
duals randomly assigned to two groups) analyses are
supported. Volcano plots are used to compare the size
of the fold change to the statistical signiﬁcance level.
The horizontal axis plots the fold change between the
two groups (on a log scale), while the vertical axis repre-
sents the P-value for a t-test of diﬀerences between sam-
ples (on a negative log scale).
Chemometric analysis path. This analysis path oﬀers
the two most commonly used chemometric methods—
principal component analysis (PCA) and partial-least
squares discriminant analysis (PLS-DA). PCA is an unsu-
pervised method aiming to ﬁnd the directions of maximum
variance in a data set (X) without referring to the class
labels (Y). PLS-DA is a supervised method that uses mul-
tiple linear regression technique to ﬁnd the direction of
maximum covariance between a data set (X) and the
class membership (Y). For both methods, the original
variables are summarized into much fewer variables
using their weighted averages. These new variables are
called scores. The weighting proﬁles are called loadings.
MetaboAnalyst provides various views commonly used
for PCA and PLS-DA analysis. Users can specify each
axis to view the patterns between diﬀerent components.
Both two-dimensional (2D) and three-dimensional (3D)
views are implemented. A 3D PLS-DA score plot is
shown in Figure 2A. As a supervised method, PLS-DA
can perform both classiﬁcation and feature selection.
The algorithm uses cross-validation to select an optimal
number of components for classiﬁcation. Two feature
importance measures are commonly used in PLS-DA.
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weighted sum of squares of the PLS loadings. The weights
are based on the amount of explained Y-variance in each
dimension. The other importance measure is based on the
weighted sum of PLS-regression coeﬃcients. The weights
are a function of the reduction of the sums of squares
across the number of PLS components. Both importance
measures are implemented in PLS-DA analysis for select-
ing important features. MetaboAnalyst’s implementation
of PLS-DA also supports several options for cross-valida-
tion including leave-one-out (LOOCV) and 10-fold cross
validation. We also implemented PLS-DA permutation
tests to help users determine the importance of class
separation (19).
Feature selection path. This analysis path provides
two well-established methods widely used for identiﬁca-
tion of diﬀerentially expressed genes in microarray
Figure 2. Examples of some of the graphical output and analyses available from MetaboAnalyst. (A) PLS-DA class separation based on the top
three components. (B) Signiﬁcant features identiﬁed by SAM analysis. (C) Heat map generated from hierarchical clustering. (D) Features ranked by
random forest. The binned NMR spectral data (test data #2) was used to generate these graphs.
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Metabolites) (SAM) (20) and Empirical Bayesian
Analysis of Microarrays (and Metabolites) (EBAM)
(21). However, these methods are very general for identi-
ﬁcation of signiﬁcant features in high-dimensional data
and are not restricted to the analysis of microarray data.
SAM is designed to address false discovery rate problems
(FDR) when running multiple tests on high-dimensional
data. It ﬁrst assigns a signiﬁcance score to each variable
based on its change relative to the standard deviation of
repeated measurements. Then it chooses variables with
scores greater than an adjustable threshold and compares
their relative diﬀerence to the distribution estimated
by random permutations of the class labels. For each
threshold, a certain proportion of the variables in the per-
mutation set will be found to be signiﬁcant by chance. The
number is used to calculate the FDR. In this way SAM is
able to perform permutation testing, something that is not
done in MetaboAnalyst’s t-tests. The EBAM algorithm is
essentially a variation of the SAM method. The only dif-
ference is that EBAM uses a modiﬁed t-statistic in calcu-
lating its score. Typical SAM and EBAM plots are
provided to assist users in choosing the best parameters
and viewing the results. Tables containing numeric
details are also available through hyperlinks in addition
to these graphical presentations. A SAM plot is shown in
Figure 2B.
Cluster analysis path. MetaboAnalyst’s cluster analysis
allows a closer interrogation of samples with similar abun-
dance proﬁles. This path includes two major approaches
of clustering analysis — hierarchical clustering and parti-
tional clustering. Hierarchical (agglomerative) clustering
begins with each sample considered as separate cluster
and then proceeds to combine them until all samples
belong to one cluster. A variety of dissimilarity measures
(Euclidean distance, Pearson’s correlation, and
Spearman’s rank correlation) and clustering methods
(average linkage, complete linkage, single linkage and
Ward’s linkage) have been implemented in
MetaboAnalyst. The result of hierarchical clustering is
usually presented as a dendrogram or heat map, both of
which are available in MetaboAnalyst. A heat map view is
presented in Figure 2C using one of our test data sets.
Partitional clustering attempts to directly decompose the
data set into a user-speciﬁed number of disjoint clusters.
Two widely used methods, k-means clustering and self-
organizing map (SOM) have been implemented in
MetaboAnalyst. k-Means clustering aims to create k clus-
ters such that the sum of squares from points to the
assigned cluster centers’ is minimized. SOM is an unsuper-
vised neural network based around the concept of a grid
of interconnected nodes, each of which contains a model.
The model clusters begin as random values, but during the
iterative training process, they are updated to represent
diﬀerent subsets of the training set. Users indicate the
cluster number by specifying the expected dimension of
the grid. The clusters from both k-means and SOM are
presented as aggregated expression proﬁles in which sam-
ples in each cluster are plotted as line graphs on top of
each other using their feature values.
Supervised classification path. Class prediction using
metabolomics data is increasingly important in studies
aiming for early diagnosis, prognosis or treatment out-
comes. MetaboAnalyst oﬀers three powerful supervised
classiﬁcation methods—PLS-DA, random forest (22)
and support vector machine (SVM). These methods have
proved to be robust for high-dimensional data and are
widely used for other ‘omics’ data analysis. In addition,
they can also help prioritize features that contribute sig-
niﬁcantly to the performance. PLS-DA based feature
selection and classiﬁcation was previously discussed in
the chemometrics path. Random forest uses an ensemble
of classiﬁcation trees, each of which is grown by random
feature selection from a bootstrap sample at each branch.
Class prediction is based on the majority vote of the
ensemble. During tree construction, about one-third of
the instances are left out of the bootstrap sample. This
data is then used as test sample to obtain an unbiased
estimate of the classiﬁcation (OOB) error. Variable impor-
tance is evaluated by measuring the increase of the OOB
error when it is permuted. Figure 2D shows the important
features ranked by random forest. The SVM classiﬁcation
algorithm aims to ﬁnd a nonlinear decision function in the
input space by mapping the data into a higher dimensional
feature space and separating it by means of a maximum
margin hyperplane (23). MetaboAnalyst’s SVM analysis is
done through recursive feature selection and sample clas-
siﬁcation using a linear kernel (24). Features are selected
based on their relative contribution in the classiﬁcation
using cross validation error rates. The least important
features are eliminated in the subsequent steps. This
process creates a series of SVM models. The features
used by the best model are considered to be important
and are ranked by their frequencies of being selected in
the model.
Step 5: Data annotation (peak search and pathway
mapping)
A key step in placing statistically signiﬁcant ﬁndings from
chemometric analyses (as opposed to quantitative meta-
bolomic analyses) into a biological context is to identify
signiﬁcantly altered compounds represented by certain
spectral bins or certain clusters of spectral peaks. Once a
user has identiﬁed lists of MS or NMR peaks that exhibit
statistically signiﬁcant changes, they may use one of sev-
eral spectral comparison routines and spectral libraries to
attempt to identify the compound(s) based on either lists
of MS peaks (from MS or MS/MS data), GC-–MS peaks
(from EI mass values and retention indices) or NMR
peaks (from
1H,
13C or heteronuclear NMR spectra).
These compound identiﬁcation routines and spectral ref-
erence libraries were originally developed for the HMDB
and for MetaboMiner (11). While not as comprehensive as
some commercial libraries or commercial software, these
freely available tools have been shown to be quite power-
ful in identifying many common compounds. Once com-
pound information becomes available (via quantitative
routes or via MetaboAnalyst’s metabolite ID software),
more insight can be obtained by which metabolic
pathways are involved. Pathway mapping has been
Nucleic AcidsResearch, 2009, Vol.37, WebServer issue W657implemented in MetaboAnalyst using more than 70 path-
way diagrams and metabolite libraries derived from the
HMDB. Users simply type the names (or synonyms) of
the metabolites identiﬁed and MetaboAnalyst provides
the list of pathways in which these metabolites are
found, along with hyperlinks to their pathway images.
All results are linked to the HMDB where users can
obtain more detailed information for each metabolite or
pathway.
Step 6: summary report download
When users ﬁnish their analyses and click the download
link, a comprehensive report will be generated containing
a detailed description of each step performed embedded
with graphical and tabular outputs. In addition, the pro-
cessed numeric data, high-resolution images (PNG
format), R scripts, as well as the R command history are
also available for downloading. Users familiar with R can
easily reproduce the results on their local machine after
installation of R and the required packages. Users have
the option of providing an email address (to which the
summary report is sent) or simply downloading the com-
pressed ﬁle that contains all the data (graphs, tables, etc.)
produced during the analysis. A sample summary report is
available for download from MetaboAnalyst’s homepage.
Raw data ﬁles are stored on the server in a temporary
folder for up to 72hrs and then deleted from the server
using an automatic ‘cron’ job. After the user has analyzed
their data and logs out (after providing their email
address) they are sent a URL via email that will allow
them to return to their analysis session. All
images, ﬁgures and tables generated by a MetaboAnalyst
session are downloadable and may be permanently stored
on the user’s own hard drive.
Tutorials and sample data sets
The inherent complexity of many data processing techni-
ques combined with lack of familiarity that many users
may have with some of the analytical approaches used
by MetaboAnalyst led us to develop a number of tutorials
and sample data sets. This was also done so that new users
could become more familiar with MetaboAnalyst’s
expected inputs and outputs. Under the ‘Try our test
data’ in the data upload window, users will ﬁnd eight dif-
ferent data sets labeled as: (i) concentrations (a metabolite
concentration table); (ii) NMR spectral bins; (iii) NMR
peak lists; (iv) concentrations (paired, time series); (v) MS
peak intensities; (vi) MS peak lists; (vii) LC-MS spectra in
NetCDF format and (viii) GC-MS spectra in NetCDF
format. Users may process these data by clicking on
the radio button beside a given data set and pressing the
Submit button. Alternately, these example data sets can be
downloaded and subsequently ‘uploaded’ using the
‘Upload your data’ section. Once a test data set is sub-
mitted (or uploaded) the user may navigate through
MetaboAnalyst in any way they choose.
MetaboAnalyst also has four step-by-step tutorials
describing several analysis paths using a number of diﬀer-
ent data sets. These tutorials are available from both the
homepage and from the data upload page. Tutorial #1
uses the Metabolite concentration list (data set #1).
Tutorial #2 uses the Binned NMR spectra (data set #2),
Tutorial #3 uses the paired concentration data (data set
#4) and Tutorial #4 uses the LC-MS spectra in NetCDF
format (data set #7). MetaboAnalyst also has 20 FAQs
to complement the information found in the tutorials.
These tutorials and FAQs will be updated frequently
based on user feedback.
Comparison to other software and limitations
Many metabolomic analyses are currently done using
local installations of commercial statistical software
packages such as MatLab, MS-Excel, SigmPlot and
SIMCA-P. SIMCA-P (Umetrics), in particular, is very
widely used by the metabolomics community. While
quite expensive, SIMCA-P oﬀers excellent graphic cap-
abilities and comprehensive analysis options for three
multivariate methods (PCA, PLS/OPLS and SIMCA).
MetaboAnalyst supports two of these multivariate meth-
ods (PCA and PLS) but it also oﬀers many other methods
(i.e. volcano plots, SAM, k-means, SOM, random forest,
SVM) not found in SIMCA-P. While MetaboAnalyst does
not have the graphical ﬂexibility of SIMCA-P, it is
designed to be more accessible (via the web), freely avail-
able, and easier to use. In addition, MetaboAnalyst pro-
vides its own metabolite and pathway identiﬁcation
tools—something that is not found in any dedicated sta-
tistical software package. However, MetaboAnalyst’s
dependence on the HMDB infrastructure means that its
coverage of plant and microbial metabolism is somewhat
incomplete.
To the best of our knowledge, the only other web
application that oﬀers a similar service to
MetaboAnalyst is MeltDB (25). MeltDB is centered on
MS-based metabolomics data storage, administration,
analysis and annotation. Unfortunately, this server
appears to have security certiﬁcate issues with a number
of common browsers (Firefox, Netscape) and requires a
user login and password to obtain access. According to
the article, MeltDB appears to oﬀer some of the features
found in MetaboAnalyst such as t-tests, volcano plots,
PCA and heat maps. However, these analyses are
restricted to GC/LC-MS data only. MetaboAnalyst pro-
vides support for many more diverse data types, more
advanced data analysis methods, more comprehensive
data annotation tools as well as automated report gener-
ation utilities.
The current implementation of MetaboAnalyst primar-
ily supports (i) biomarker discovery and (ii) two-group
discrimination. We believe these kinds of analyses are
most relevant to the widest range of metabolomics studies.
Multiclass problems can always be converted into a series
of two-class problems through pair-wise decomposition.
Temporal studies (more than two time points) can be
treated as a special case of multi-class problem and
decomposed into a series of paired two-group analyses
(see Tutorial #3 for an example of a time series analysis).
We hope to add more functions to support simultaneous
analysis of multiple time-points in the near future.
W658 Nucleic Acids Research, 2009, Vol. 37,WebServer issueMetaboAnalyst makes extensive use of high-level
data inputs (i.e. concentrations, peak lists) that requires
users to perform some manual processing steps prior to
uploading the data. The support for raw or partially
processed GC-MS and LC-MS spectra is currently
achieved through the XCMS package (14). However, soft-
ware to handle unprocessed NMR spectra is not so readily
available. Steps such as phasing, baseline correction, refer-
encing, peak detection and deconvolution must be manu-
ally checked by an experienced analyst to ensure the
integrity of the results. As a result, MetaboAnalyst does
not accept raw NMR spectra. Likewise, MetaboAnalyst is
not (yet) capable of handling or interpreting capillary elec-
trophoretic (CE) data, FTIR data, coulometric electrode
array (CEA) data or raw chromatographic (HPLC or
UPLC) data. Certainly if the user community grows sig-
niﬁcantly in these areas, eﬀorts will be made to accommo-
date these analytical platforms. Indeed, MetaboAnalyst’s
modular and ﬂexible framework should facilitate future
development eﬀorts to keep up with this fast-changing
ﬁeld.
CONCLUSIONS
MetaboAnalyst is a comprehensive, web-based tool
designed to facilitate high-throughput metabolomics stu-
dies. It accepts a variety of input data (NMR peak lists,
binned NMR or MS spectra, MS peak lists, compound/
concentration data) in a wide variety of formats. It also
oﬀers a number of options for metabolomic data proces-
sing, data normalization, multivariate statistical analysis,
graphing, metabolite identiﬁcation and pathway mapping.
Through its intuitive interface and high quality graphics,
users are presented with data overviews from diﬀerent
perspectives (i.e. PCA plots, heat maps), lists of candidate
biomarkers identiﬁed by simple univariate analysis (i.e.
volcano plots), as well as estimated classiﬁcation perfor-
mances by several powerful algorithms (i.e. random forest,
SVM). Further biological insight can be gained by tapping
into the HMDB using MetaboAnalyst’s annotation tools.
MetaboAnalyst’s structured navigation, extensive docu-
mentation, as well as its comprehensive analysis reports
should allow new users to analyze their data without
signiﬁcant training or without signiﬁcant likelihood of
statistical misadventure.
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